5′-nucleotidase activity is altered by hypo- and hyperthyroidism in platelets from adult rats

Thyroid disorders are associated to a number of vascular diseases that involve processes such as platelet aggregation and vascular tone control. Since, these processes can be also affected by ATP, ADP and adenosine levels, we investigate the hydrolysis of these nucleotides in platelets from hyperthyroid, hypothyroid, and hypothyroid with hormonal replacement rats. Hyperthyroidism was induced by daily injections of L-thyroxine (T4) 25 μg/100 g body weight for 14 days. Hypothyroidism was induced by thyroidectomy and methimazole (0.05%) for 14 days. In the hormonal replacement group, hypothyroid rats were injected with T4 (5 μg/100 g body weight, i.p.) for 5 days. The AMP hydrolysis by platelets was increased 49% in hyperthyroid rats and decreased 50% in response to hypothyroidism, while the ATP and ADP hydrolysis was not altered in both groups. Besides, the T4 replacement significantly reversed the inhibition of the AMP hydrolysis observed in hypothyroid rats. Our findings indicate that the thyroid disorders affect the 5′-nucleotidase activity and consequently can alter the adenosine levels in a reversible manner in platelet fraction. Since, adenosine is able to inhibit platelet aggregation and acts as a potent vasodilator, these results can contribute to a better comprehension of the vascular events described in thyroid disorders.

[1]  M. Carneiro-Ramos,et al.  Thyroid hormone stimulates 5′-ecto-nucleotidase of neonatal rat ventricular myocytes , 2004, Molecular and Cellular Biochemistry.

[2]  R. Dias,et al.  Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets , 1993, Molecular and Cellular Biochemistry.

[3]  C. Bonan,et al.  Hyperthyroidism modifies ecto-nucleotidase activities in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development , 2003, International Journal of Developmental Neuroscience.

[4]  G. Burnstock,et al.  Involvement of purinergic signaling in cardiovascular diseases. , 2003, Drug news & perspectives.

[5]  C. Erem,et al.  BLOOD COAGULATION AND FIBRINOLYTIC ACTIVITY IN HYPOTHYROIDISM , 2003, International journal of clinical practice.

[6]  C. Gachet ADP Receptors of Platelets and their Inhibition , 2001, Thrombosis and Haemostasis.

[7]  G. Burnstock,et al.  P2 purinergic receptors: modulation of cell function and therapeutic potential. , 2000, The Journal of pharmacology and experimental therapeutics.

[8]  T. Nagasawa,et al.  Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells. , 2000, Blood.

[9]  D. Cokkinos,et al.  Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts. , 2000, Journal of cardiovascular pharmacology.

[10]  H. Kogo,et al.  Changes in vascular reactivity induced by acute hyperthyroidism in isolated rat aortae. , 2000, General Pharmacology.

[11]  M. Williams,et al.  Purinergic and pyrimidinergic receptors as potential drug targets. , 2000, Biochemical pharmacology.

[12]  G. Burnstock,et al.  Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells , 2000, British journal of pharmacology.

[13]  E. Picano,et al.  Increase in plasma adenosine during brain ischemia in man: A study during transient ischemic attacks, and stroke , 2000, Brain Research Bulletin.

[14]  L. Calzà,et al.  Thyroid Hormone-Induced Plasticity in the Adult Rat Brain , 1997, Brain Research Bulletin.

[15]  R. Salín-Pascual,et al.  Differences in sleep variables, blood adenosine, and body temperature between hypothyroid and euthyroid rats before and after REM sleep deprivation. , 1997, Sleep.

[16]  M. Hagiwara,et al.  Alteration of platelet aggregation in patients with thyroid disorders. , 1997, Metabolism: clinical and experimental.

[17]  A. Marcus,et al.  The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. , 1997, The Journal of clinical investigation.

[18]  G. Soslau,et al.  A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. , 1997, Biochimica et biophysica acta.

[19]  J. L. Leonard,et al.  Thyroid hormone-regulated actin polymerization in brain. , 1997, Thyroid : official journal of the American Thyroid Association.

[20]  J. Floras,et al.  Cardiovascular pharmacology of purines. , 1997, Clinical science.

[21]  J. V. Martin,et al.  Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain , 1996, Neuroscience.

[22]  P. Sullivan,et al.  Thyroxine Suppresses Thrombocytopoiesis and Stimulates Erythropoiesis in Mice , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  J. Pearson,et al.  Metabolism of Adenine Nucleotides in Human Blood , 1989, Circulation research.

[24]  M. Hagiwara,et al.  Thyroid hormones inhibit platelet function and myosin light chain kinase. , 1989, The Journal of biological chemistry.

[25]  K. Chan,et al.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity. , 1986, Analytical biochemistry.

[26]  B. Folkow,et al.  Structural adaptation of the rat left ventricle in response to changes in pressure and volume loads. , 1985, Acta physiologica Scandinavica.

[27]  R. Hantgan A study of the kinetics of ADP-triggered platelet shape change. , 1984, Blood.

[28]  J. Bilezikian,et al.  The Influence of Hyperthyroidism and Hypothyroidism on α and β-Adrenergic Receptor Systems and Adrenergic Responsiveness* , 1983 .

[29]  M. Ranieri-Raggi,et al.  Effect of pH on the kinetic properties of rat skeletal muscle AMP deaminase. , 1980, The Italian journal of biochemistry.

[30]  C. Bergamini,et al.  Human platelets 5'-nucleotidase: a cell membrane ectoenzyme with a possible regulatory role in the aggregation reaction. , 1980, The Italian journal of biochemistry.

[31]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[32]  H. J. Berman,et al.  Gel Filtration , 1971, Thrombosis and Haemostasis.

[33]  R. M.,et al.  The Thyroid Gland , 1894, Nature.